Karpus Investment Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Karpus Investment Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-228,558	Closed	-$2.3M	–	458
2022 Q4	$2.3M	Sell	228,558 -7,125	-3%	-$71.1K	0.08%	198
2022 Q3	$2.33M	Sell	235,683 -18,825	-7%	-$185K	0.08%	229
2022 Q2	$2.49M	Sell	254,508 -1,725	-0.7%	-$16.9K	0.08%	232
2022 Q1	$2.51M	Buy	256,233 +167,025	+187%	+$1.63M	0.08%	209
2021 Q4	$864K	Buy	+89,208	New	+$867K	0.02%	271

Karpus Investment Management's MSAC Position: Q1 2023 in Review

Karpus Investment Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 228,558 shares — an estimated $2.3M sold.

Karpus Investment Management first reported a position in MSAC in Q4 2021 and held it in 5 quarters. The position peaked at $2.51M in Q1 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Karpus Investment Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Karpus Investment Management sold 228,558 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $2.3M.
Karpus Investment Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
Karpus Investment Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $2.51M in Q1 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Karpus Investment Management's 13F filing for Q1 2023, filed 11 May 2023.